 "Jubilant Lifesciences gains on USFDA nod for generic Mycophenolate Mofetil and Rizatriptan")
Mycophenolate Mofetil USP, 250mg capsules and 500mg tablets is the generic version of Cellcept (Roche), an immunosuppressant which is used to help prevent organ rejection in transplants. The annual market size in the US as per IMS is $245 million, the company said in a release.
Rizatriptan tablets 5mg and 10mg is the generic version of Maxalt (Merck) used for the treatment of migraine. The annual market size for these tablets is $70 million, the release said.
The stock opened at Rs 148 and touched a high of Rs 154. At 9:35AM, over 540,000 shares were traded on both the stock exchanges.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →*Subscribe to Business Standard digital and get complimentary access to The New York Times
Smart Quarterly
₹900
3 Months
₹300/Month
SAVE 25%
Smart Essential
₹2,700
1 Year
₹225/Month
SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months
Super Saver
₹3,900
2 Years
₹162/Month
Subscribe
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
SAVE 25%